Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
about
Which health technologies should be funded? A prioritization framework based explicitly on value for moneyMulti-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugsTowards generic online multicriteria decision support in patient-centred health careAppraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.Multicriteria decision analysis in oncology.Does technique matter; a pilot study exploring weighting techniques for a multi-criteria decision support framework.Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study.Addressing preference heterogeneity in public health policy by combining Cluster Analysis and Multi-Criteria Decision Analysis: Proof of Method.Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation.Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis.Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in BulgariaAssessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature.Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.What factors determine the choice of public engagement undertaken by health technology assessment decision-making organizations?Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea.Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran.GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONS.Sustainability in Health care by Allocating Resources Effectively (SHARE) 9: conceptualising disinvestment in the local healthcare setting.Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016.Using multi-criteria decision analysis to appraise orphan drugs: a systematic review.Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States.Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).DRUG EVALUATION AND DECISION MAKING IN CATALONIA: DEVELOPMENT AND VALIDATION OF A METHODOLOGICAL FRAMEWORK BASED ON MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR ORPHAN DRUGS.Using multicriteria decision analysis during drug development to predict reimbursement decisions.Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis.Australian Public Preferences for the Funding of New Health TechnologiesMulti-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs-a Systematic Literature Review. Next Steps in Methodology Development?HTA and MCDA solely or combined? The case of priority-setting in ColombiaCan reflective multicriteria be the new paradigm for healthcare decision-making? The EVIDEM journey
P2860
Q21195870-39509493-B48E-4363-81DB-36E020C56D4BQ28468294-5783369C-8370-416E-9F00-4B75E70C48E3Q30352572-ED3BA4E9-ECED-4130-8017-0E0EDF4C59EAQ33568653-234652EC-6106-4625-8E4B-9662D21C47F9Q35054713-CE54040E-5B75-4E4F-8236-067496794AFCQ35521438-919A5259-8C49-4CDD-AD11-2837B0783E89Q35583822-2D20C905-BF46-4B76-8DAE-D5888E2A7B38Q35599455-9E632E89-A4B9-4FC6-B7D6-913B8BB73CB6Q35685387-3BFBA17B-84C3-44FA-A848-929AA147A4F8Q35835153-1B63F8F3-AA78-4930-ABFB-FCB319161A2AQ35857625-D3D4DAA2-7A08-4ABE-8D1A-46AD4D8E88AFQ35898829-C69CDA8E-541B-465B-B870-00BF9A175A25Q36150233-DA15BDFF-A5D5-417E-85DE-03011AE7AB47Q36618422-F3792C65-9DD4-435B-BB49-59394D73AEF5Q38185989-3B9CA02C-0C1F-45AF-B265-CA7043F7F6DFQ38947965-5EE03CF1-346D-456F-87D3-563D0E9FB4ABQ38966920-C16E03A5-8087-4F5A-BD11-73C0A25FA0E7Q39055438-B114AA68-FB68-4CE6-8E8C-61DC41F7561DQ39063322-52787F45-A4FF-4B33-A495-6F41394EC6DBQ40143602-955FAC38-5256-434C-8987-3961CAD7A82BQ41467201-A6C4AEFD-6178-4D8B-B4FF-1E689697D762Q42682620-BCC26FAA-153D-495C-9A6B-BFC28567EB22Q48169439-81508D84-4868-40E9-B4A2-7D421F89D583Q48360739-F9C33E0A-7C01-42AD-BA0A-AEE7634D17C4Q52603250-8C38338C-BFBE-4085-80B9-F3B9E82982C7Q53836366-3EF4FD58-4613-4252-BB09-80DDC84AB9F3Q55261344-7F58EB32-BAFF-444D-A7D4-334349DEC41DQ55360994-CA5F12D6-D1A8-4060-9763-91E10E13975FQ57574202-007CB4EC-FE23-40F8-A122-5F59D130A96BQ58122261-CBD016EA-164E-49CF-95B2-B82D22917657Q59130346-D2F9A358-68B4-4561-88D7-95231A189B77Q59130348-2DEE8C69-2F96-4403-AB5A-F386EA937417
P2860
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bridging health technology ass ...... s by a public payer in Canada.
@ast
Bridging health technology ass ...... s by a public payer in Canada.
@en
type
label
Bridging health technology ass ...... s by a public payer in Canada.
@ast
Bridging health technology ass ...... s by a public payer in Canada.
@en
prefLabel
Bridging health technology ass ...... s by a public payer in Canada.
@ast
Bridging health technology ass ...... s by a public payer in Canada.
@en
P2093
P2860
P356
P1476
Bridging health technology ass ...... s by a public payer in Canada.
@en
P2093
Donna Rindress
Hanane Khoury
Michèle Tony
Mireille M Goetghebeur
Monika Wagner
Tina Papastavros
P2860
P2888
P356
10.1186/1472-6963-11-329
P577
2011-11-30T00:00:00Z
P5875
P6179
1005161727